| Literature DB >> 28100833 |
Constantinos Petrovas1, Sara Ferrando-Martinez2, Michael Y Gerner3, Joseph P Casazza2, Amarendra Pegu4, Claire Deleage5, Arik Cooper4, Jason Hataye2, Sarah Andrews6, David Ambrozak2, Perla M Del Río Estrada7, Eli Boritz8, Robert Paris9, Eirini Moysi2, Kristin L Boswell2, Ezequiel Ruiz-Mateos10, Ilias Vagios11, Manuel Leal10, Yuria Ablanedo-Terrazas7, Amaranta Rivero7, Luz Alicia Gonzalez-Hernandez7, Adrian B McDermott6, Susan Moir12, Gustavo Reyes-Terán7, Fernando Docobo10, Giuseppe Pantaleo13, Daniel C Douek8, Michael R Betts14, Jacob D Estes5, Ronald N Germain3, John R Mascola4, Richard A Koup2.
Abstract
Cytolytic CD8 T cells play a crucial role in the control and elimination of virus-infected cells and are a major focus of HIV cure efforts. However, it has been shown that HIV-specific CD8 T cells are infrequently found within germinal centers (GCs), a predominant site of active and latent HIV infection. We demonstrate that HIV infection induces marked changes in the phenotype, frequency, and localization of CD8 T cells within the lymph node (LN). Significantly increased frequencies of CD8 T cells in the B cell follicles and GCs were found in LNs from treated and untreated HIV-infected individuals. This profile was associated with persistent local immune activation but did not appear to be directly related to local viral replication. Follicular CD8 (fCD8) T cells, despite compromised cytokine polyfunctionality, showed good cytolytic potential characterized by high ex vivo expression of granzyme B and perforin. We used an anti-HIV/anti-CD3 bispecific antibody in a redirected killing assay and found that fCD8 T cells had better killing activity than did non-fCD8 T cells. Our results indicate that CD8 T cells with potent cytolytic activity are recruited to GCs during HIV infection and, if appropriately redirected to kill HIV-infected cells, could be an effective component of an HIV cure strategy.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28100833 PMCID: PMC5497679 DOI: 10.1126/scitranslmed.aag2285
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956